113 Shares in The Cooper Companies, Inc. (NYSE:COO) Acquired by General Partner Inc.

General Partner Inc. acquired a new position in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 113 shares of the medical device company’s stock, valued at approximately $37,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Citadel Advisors LLC raised its position in Cooper Companies by 122.7% in the third quarter. Citadel Advisors LLC now owns 56,089 shares of the medical device company’s stock valued at $14,802,000 after purchasing an additional 30,899 shares during the period. Eaton Vance Management grew its stake in shares of Cooper Companies by 17.0% in the third quarter. Eaton Vance Management now owns 86,091 shares of the medical device company’s stock valued at $22,720,000 after buying an additional 12,525 shares in the last quarter. Trexquant Investment LP acquired a new stake in shares of Cooper Companies in the third quarter valued at $4,195,000. United Capital Financial Advisers LLC grew its stake in shares of Cooper Companies by 10.5% in the second quarter. United Capital Financial Advisers LLC now owns 1,007 shares of the medical device company’s stock valued at $315,000 after buying an additional 96 shares in the last quarter. Finally, Prudential PLC grew its stake in shares of Cooper Companies by 17.7% in the third quarter. Prudential PLC now owns 1,271 shares of the medical device company’s stock valued at $335,000 after buying an additional 191 shares in the last quarter. Hedge funds and other institutional investors own 96.78% of the company’s stock.

Cooper Companies Stock Performance

COO opened at $341.50 on Friday. The stock has a market cap of $16.89 billion, a P/E ratio of 45.23, a P/E/G ratio of 2.42 and a beta of 0.89. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.72 and a quick ratio of 1.00. The stock’s 50 day simple moving average is $342.01 and its 200 day simple moving average is $312.30. The Cooper Companies, Inc. has a 1-year low of $244.21 and a 1-year high of $429.89.

Cooper Companies (NYSE:COO – Get Rating) last released its quarterly earnings results on Thursday, March 2nd. The medical device company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.66 by $0.24. The business had revenue of $858.50 million for the quarter, compared to analysts’ expectations of $834.90 million. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The company’s revenue was up 9.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.24 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 12.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on COO. Citigroup lifted their price objective on Cooper Companies from $348.00 to $368.00 and gave the company a “buy” rating in a research note on Monday, December 12th. StockNews.com began coverage on Cooper Companies in a research note on Thursday. They set a “hold” rating for the company. Robert W. Baird boosted their target price on Cooper Companies from $371.00 to $385.00 in a research note on Friday, March 3rd. Mizuho boosted their target price on Cooper Companies from $385.00 to $390.00 in a research note on Friday, March 3rd. Finally, JPMorgan Chase & Co. boosted their target price on Cooper Companies from $300.00 to $330.00 in a research note on Monday, November 28th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus target price of $382.60.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Jody S. Lindell sold 1,000 shares of the stock in a transaction on Friday, January 6th. The stock was sold at an average price of $344.30, for a total transaction of $344,300.00. Following the sale, the director now owns 13,543 shares in the company, valued at approximately $4,662,854.90. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Cooper Companies news, COO Gerard H. Warner III sold 1,216 shares of the stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $340.53, for a total transaction of $414,084.48. Following the transaction, the chief operating officer now owns 1,290 shares of the company’s stock, valued at approximately $439,283.70. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jody S. Lindell sold 1,000 shares of the stock in a transaction on Friday, January 6th. The stock was sold at an average price of $344.30, for a total value of $344,300.00. Following the transaction, the director now directly owns 13,543 shares in the company, valued at approximately $4,662,854.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,726 shares of company stock worth $13,426,262. 2.00% of the stock is owned by insiders.

Cooper Companies Profile

(Get Rating)

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.